MSH|^~\&#|STARLIMS.CDC.Prod^2.16.840.1.114222.4.3.3.2.1.1^ISO|CDC FTC^06D0880233^CLIA|CLIMS.NY.Stag^2.16.840.1.114222.4.3.3.2.17.2^ISO|NYSDOH^2.16.840.1.114222.4.1.3673^ISO|20230601153856-0400||ORU^R01^ORU_R01|3029198209_3029198209_5121|P|2.5.1|||NE|NE|USA|UNICODE UTF-8|||PHLabReport-NoAck^PHIN^2.16.840.1.113883.9.11^ISO
SFT|CDC^^^^^CDC&2.16.840.1.114222.4&ISO^XX^^^CDC CLIA|ELIMS V11|STARLIMS|Binary ID unknown
PID|1||FPID00006731^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^PI~IDR2200064353^^^SPHL-000026&2.16.840.1.114222.4.1.3673&ISO^PI||Haddock^Hiccup^^^^^L||19950323|M|||^^^^^USA^H
NTE|1|L|SPHL Submitter: NYSDOH Wadsworth Center, Diag. Immunology Lab, Submitter ID: SPHL-000026, Address: Axelrod Institute 120 New Scotland Avenue Albany, New York 12208 United States, Email: dilab@health.ny.gov, Submitter Patient ID: IDR2200064353, Submitter Alt Patient ID: , Submitter Specimen ID: IDR2200064353, Submitter Alt Specimen ID:|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
NTE|2|L|Original Submitter: Westchester Medical Center, Submitter ID: FTC-3218, Address: 100 Woods Rd  Valhalla, New York 10595 United States, Email: , Submitter Patient ID: , Submitter Alt Patient ID: , Submitter Specimen ID: , Submitter Alt Specimen ID:|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
NTE|3|L|02/10/2023: Final Report,  05/31/2023: Jamestown Canyon Plaque Reduction Neutralization Result Changed (ZZYSDZF4): Jamestown Canyon Plaque Reduction Neutralization - from '1280' to '640',  05/31/2023: La Crosse Plaque Reduction Neutralization Result Changed (ZZYSDZF4): La Crosse Plaque Reduction Neutralization - from '1280' to '320'|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
ORC|RE|IDR2200064353^SPHL-000026^2.16.840.1.114222.4.1.3673^ISO|3029198209_3029198209^STARLIMS.CDC.Prod^2.16.840.1.114222.4.3.3.2.1.1^ISO||||||20230103|||FTC-3218^Westchester Medical Center^^^^^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^^^^XX|||||||||NYSDOH Wadsworth Center, Diag. Immunology Lab^D^^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^XX^^^SPHL-000026|Axelrod Institute^120 New Scotland Avenue^Albany^NY^12208^USA^M|^NET^Internet^dilab@health.ny.gov|100 Woods Rd^^Valhalla^NY^10595^USA^M
OBR|1|IDR2200064353^SPHL-000026^2.16.840.1.114222.4.1.3673^ISO|3029198209_3029198209^STARLIMS.CDC.Prod^2.16.840.1.114222.4.3.3.2.1.1^ISO|68991-9^Epidemiologically Important Information^LN^^^^2.69^^^CDC-10282^Arbovirus Serology^L^^2.16.840.1.113883.6.1|||20221227|||||||||FTC-3218^Westchester Medical Center^^^^^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^^^^XX||||||20230601153800-0400|||F
OBX|1|DT|11368-8^Illness or injury onset date and time^LN^^^^2.61||20221114||||||F|||20221227|06D0880233^CDC Division of Vector-Borne Infectious Diseases^CLIA||||20230106160548+0000||||Centers for Disease Control and Prevention^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^06D0880233|3156 Rampart Road^^Fort Collins^CO^80521^USA^B
OBX|2|SN|21612-7^Reported Patient Age^LN^^^^2.61||^43|a^Year^UCUM^^^^2.1|||||F|||20221227|06D0880233^CDC Division of Vector-Borne Infectious Diseases^CLIA||||20230106160548+0000||||Centers for Disease Control and Prevention^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^06D0880233|3156 Rampart Road^^Fort Collins^CO^80521^USA^B
SPM|1|IDR2200064353&SPHL-000026&2.16.840.1.114222.4.1.3673&ISO^3029198209&STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO||119364003^Serum specimen^SCT^SER^Serum specimen^L^0912017^Adobe_Code^Serum specimen||||||||||Original material,|||20221227|20230104140813+0000||||||44639001^Dry Ice^SCT^^^^09012017^^Frozen (Dry Ice)
OBR|2|IDR2200064353^SPHL-000026^2.16.840.1.114222.4.1.3673^ISO|72_3029198209_3029198209_716^STARLIMS.CDC.Prod^2.16.840.1.114222.4.3.3.2.1.1^ISO|PLT1141^JCV IgM XXX Ql IA^PLT^716^JC IgM^L^2.69^v unknown^^CDC-10282^Arbovirus Serology^L^^2.16.840.1.113883.6.1|||20221227|||||||||FTC-3218^Westchester Medical Center^^^^^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^^^^XX||||||20230601134600-0400|||C
NTE|1|L|Test has not been cleared or approved by the FDA. The Performance characteristics have been establis|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
NTE|2|L|Evidence of recent infection with Powassan virus and a previous infection with a California serogroup virus (likely Jamestown Canyon virus). Clinical correlation required.|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
OBX|1|CWE|PLT1141^JCV IgM XXX Ql IA^PLT^2647^Jamestown Canyon IgM Capture ELISA^L^2.69^v_unknown^Jamestown Canyon IgM Capture ELISA|ZZYSDZF4-1|10828004^Positive^SCT^^^^09012018^^Positive||||||C|||20221227|06D0880233^CDC Division of Vector-Borne Infectious Diseases^CLIA^72^Arbovirus Diseases Branch^L|AHK7@cdc.gov^Lambert^Amy|||20230106160548+0000||||CDC Division of Vector-Borne Infectious Diseases^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^06D0880233|3156 Rampart Road^^Fort Collins^CO^80521^USA^B
SPM|1|IDR2200064353&SPHL-000026&2.16.840.1.114222.4.1.3673&ISO^3029198209&STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO||119364003^Serum specimen^SCT^SER^Serum specimen^L^0912017^Adobe_Code^Serum specimen||||||||||Original material,|||20221227|20230104140813+0000||||||44639001^Dry Ice^SCT^^^^09012017^^Frozen (Dry Ice)
OBR|3|IDR2200064353^SPHL-000026^2.16.840.1.114222.4.1.3673^ISO|72_3029198209_3029198209_718^STARLIMS.CDC.Prod^2.16.840.1.114222.4.3.3.2.1.1^ISO|PLT1095^LACV IgM XXX Ql IA^PLT^718^LAC IgM^L^2.69^v unknown^^CDC-10282^Arbovirus Serology^L^^2.16.840.1.113883.6.1|||20221227|||||||||FTC-3218^Westchester Medical Center^^^^^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^^^^XX||||||20230601134600-0400|||C
NTE|1|L|Test has not been cleared or approved by the FDA. The Performance characteristics have been establis|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
NTE|2|L|Evidence of recent infection with Powassan virus and a previous infection with a California serogroup virus (likely Jamestown Canyon virus). Clinical correlation required.|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
OBX|1|CWE|PLT1095^LACV IgM XXX Ql IA^PLT^2649^La Crosse IgM Capture ELISA^L^2.69^v_unknown^La Crosse IgM Capture ELISA|ZZYSDZF4-1|260385009^Negative^SCT^^^^09012018^^Negative||||||C|||20221227|06D0880233^CDC Division of Vector-Borne Infectious Diseases^CLIA^72^Arbovirus Diseases Branch^L|AHK7@cdc.gov^Lambert^Amy|||20230106160548+0000||||CDC Division of Vector-Borne Infectious Diseases^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^06D0880233|3156 Rampart Road^^Fort Collins^CO^80521^USA^B
SPM|1|IDR2200064353&SPHL-000026&2.16.840.1.114222.4.1.3673&ISO^3029198209&STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO||119364003^Serum specimen^SCT^SER^Serum specimen^L^0912017^Adobe_Code^Serum specimen||||||||||Original material,|||20221227|20230104140813+0000||||||44639001^Dry Ice^SCT^^^^09012017^^Frozen (Dry Ice)
OBR|4|IDR2200064353^SPHL-000026^2.16.840.1.114222.4.1.3673^ISO|72_3029198209_3029198209_722^STARLIMS.CDC.Prod^2.16.840.1.114222.4.3.3.2.1.1^ISO|PLT1097^POWV IgM XXX Ql IA^PLT^722^POW IgM^L^2.69^v unknown^^CDC-10282^Arbovirus Serology^L^^2.16.840.1.113883.6.1|||20221227|||||||||FTC-3218^Westchester Medical Center^^^^^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^^^^XX||||||20230601134600-0400|||C
NTE|1|L|Test has not been cleared or approved by the FDA. The Performance characteristics have been establis|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
NTE|2|L|Evidence of recent infection with Powassan virus and a previous infection with a California serogroup virus (likely Jamestown Canyon virus). Clinical correlation required.|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
OBX|1|CWE|PLT1097^POWV IgM XXX Ql IA^PLT^2653^Powassan IgM Capture ELISA^L^2.69^v_unknown^Powassan IgM Capture ELISA|ZZYSDZF4-1|10828004^Positive^SCT^^^^09012018^^Positive||||||C|||20221227|06D0880233^CDC Division of Vector-Borne Infectious Diseases^CLIA^72^Arbovirus Diseases Branch^L|AHK7@cdc.gov^Lambert^Amy|||20230106160548+0000||||CDC Division of Vector-Borne Infectious Diseases^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^06D0880233|3156 Rampart Road^^Fort Collins^CO^80521^USA^B
SPM|1|IDR2200064353&SPHL-000026&2.16.840.1.114222.4.1.3673&ISO^3029198209&STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO||119364003^Serum specimen^SCT^SER^Serum specimen^L^0912017^Adobe_Code^Serum specimen||||||||||Original material,|||20221227|20230104140813+0000||||||44639001^Dry Ice^SCT^^^^09012017^^Frozen (Dry Ice)
OBR|5|IDR2200064353^SPHL-000026^2.16.840.1.114222.4.1.3673^ISO|72_3029198209_3029198209_765^STARLIMS.CDC.Prod^2.16.840.1.114222.4.3.3.2.1.1^ISO|PLT805^JCV Ab Titr Spec Nt^PLT^765^JC PRNT^L^2.69^v unknown^^CDC-10282^Arbovirus Serology^L^^2.16.840.1.113883.6.1|||20221227|||||||||FTC-3218^Westchester Medical Center^^^^^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^^^^XX||||||20230601134600-0400|||C
NTE|1|L|Test has not been cleared or approved by the FDA. The Performance characteristics have been establis|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
NTE|2|L|Evidence of recent infection with Powassan virus and a previous infection with a California serogroup virus (likely Jamestown Canyon virus). Clinical correlation required.|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
OBX|1|SN|PLT805^JCV Ab Titr Spec Nt^PLT^2696^Jamestown Canyon Plaque Reduction Neutralization^L^2.69^v_unknown^Jamestown Canyon Plaque Reduction Neutralization|ZZYSDZF4-1|=^1^:^640|{titer}^Titer^UCUM^^^^2.1|<10 = Negative|POS^Positive^HL70078^10828004^Positive^SCT^2.7^09012017^1:640^^^^^2.16.840.1.113883.12.78|||C|||20221227|06D0880233^CDC Division of Vector-Borne Infectious Diseases^CLIA^72^Arbovirus Diseases Branch^L|AHK7@cdc.gov^Lambert^Amy|||20230120073538+0000||||CDC Division of Vector-Borne Infectious Diseases^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^06D0880233|3156 Rampart Road^^Fort Collins^CO^80521^USA^B
SPM|1|IDR2200064353&SPHL-000026&2.16.840.1.114222.4.1.3673&ISO^3029198209&STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO||119364003^Serum specimen^SCT^SER^Serum specimen^L^0912017^Adobe_Code^Serum specimen||||||||||Original material,|||20221227|20230104140813+0000||||||44639001^Dry Ice^SCT^^^^09012017^^Frozen (Dry Ice)
OBR|6|IDR2200064353^SPHL-000026^2.16.840.1.114222.4.1.3673^ISO|72_3029198209_3029198209_767^STARLIMS.CDC.Prod^2.16.840.1.114222.4.3.3.2.1.1^ISO|PLT790^LACV Ab Titr Spec Nt^PLT^767^LAC PRNT^L^2.69^v unknown^^CDC-10282^Arbovirus Serology^L^^2.16.840.1.113883.6.1|||20221227|||||||||FTC-3218^Westchester Medical Center^^^^^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^^^^XX||||||20230601134600-0400|||C
NTE|1|L|Test has not been cleared or approved by the FDA. The Performance characteristics have been establis|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
NTE|2|L|Evidence of recent infection with Powassan virus and a previous infection with a California serogroup virus (likely Jamestown Canyon virus). Clinical correlation required.|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
OBX|1|SN|PLT790^LACV Ab Titr Spec Nt^PLT^2698^La Crosse Plaque Reduction Neutralization^L^2.69^v_unknown^La Crosse Plaque Reduction Neutralization|ZZYSDZF4-1|=^1^:^320|{titer}^Titer^UCUM^^^^2.1|<10 = Negative|POS^Positive^HL70078^10828004^Positive^SCT^2.7^09012017^1:320^^^^^2.16.840.1.113883.12.78|||C|||20221227|06D0880233^CDC Division of Vector-Borne Infectious Diseases^CLIA^72^Arbovirus Diseases Branch^L|AHK7@cdc.gov^Lambert^Amy|||20230120073538+0000||||CDC Division of Vector-Borne Infectious Diseases^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^06D0880233|3156 Rampart Road^^Fort Collins^CO^80521^USA^B
SPM|1|IDR2200064353&SPHL-000026&2.16.840.1.114222.4.1.3673&ISO^3029198209&STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO||119364003^Serum specimen^SCT^SER^Serum specimen^L^0912017^Adobe_Code^Serum specimen||||||||||Original material,|||20221227|20230104140813+0000||||||44639001^Dry Ice^SCT^^^^09012017^^Frozen (Dry Ice)
OBR|7|IDR2200064353^SPHL-000026^2.16.840.1.114222.4.1.3673^ISO|72_3029198209_3029198209_772^STARLIMS.CDC.Prod^2.16.840.1.114222.4.3.3.2.1.1^ISO|PLT796^POWV Ab Titr Spec Nt^PLT^772^POW PRNT^L^2.69^v unknown^^CDC-10282^Arbovirus Serology^L^^2.16.840.1.113883.6.1|||20221227|||||||||FTC-3218^Westchester Medical Center^^^^^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^^^^XX||||||20230601134600-0400|||C
NTE|1|L|Test has not been cleared or approved by the FDA. The Performance characteristics have been establis|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
NTE|2|L|Evidence of recent infection with Powassan virus and a previous infection with a California serogroup virus (likely Jamestown Canyon virus). Clinical correlation required.|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
OBX|1|SN|PLT796^POWV Ab Titr Spec Nt^PLT^2703^Powassan Plaque Reduction Neutralization^L^2.69^v_unknown^Powassan Plaque Reduction Neutralization|ZZYSDZF4-1|=^1^:^160|{titer}^Titer^UCUM^^^^2.1|<10 = Negative|POS^Positive^HL70078^10828004^Positive^SCT^2.7^09012017^1:160^^^^^2.16.840.1.113883.12.78|||C|||20221227|06D0880233^CDC Division of Vector-Borne Infectious Diseases^CLIA^72^Arbovirus Diseases Branch^L|AHK7@cdc.gov^Lambert^Amy|||20230120073641+0000||||CDC Division of Vector-Borne Infectious Diseases^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^06D0880233|3156 Rampart Road^^Fort Collins^CO^80521^USA^B
SPM|1|IDR2200064353&SPHL-000026&2.16.840.1.114222.4.1.3673&ISO^3029198209&STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO||119364003^Serum specimen^SCT^SER^Serum specimen^L^0912017^Adobe_Code^Serum specimen||||||||||Original material,|||20221227|20230104140813+0000||||||44639001^Dry Ice^SCT^^^^09012017^^Frozen (Dry Ice)
OBR|8|IDR2200064353^SPHL-000026^2.16.840.1.114222.4.1.3673^ISO|72_3029198209_3029198209_781^STARLIMS.CDC.Prod^2.16.840.1.114222.4.3.3.2.1.1^ISO|PLT1099^EEE IgM XXX Ql IA.micro^PLT^781^EEE MIA^L^2.69^v unknown^^CDC-10282^Arbovirus Serology^L^^2.16.840.1.113883.6.1|||20221227|||||||||FTC-3218^Westchester Medical Center^^^^^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^^^^XX||||||20230601134600-0400|||C
NTE|1|L|Test has not been cleared or approved by the FDA. The Performance characteristics have been establis|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
NTE|2|L|Evidence of recent infection with Powassan virus and a previous infection with a California serogroup virus (likely Jamestown Canyon virus). Clinical correlation required.|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
OBX|1|CWE|PLT1099^EEE IgM XXX Ql IA.micro^PLT^2713^Eastern Equine Encephalitis IgM MIA^L^2.69^v_unknown^EEE MIA Result|ZZYSDZF4-1|260385009^Negative^SCT^^^^09012018^^Negative||||||C|||20221227|06D0880233^CDC Division of Vector-Borne Infectious Diseases^CLIA^72^Arbovirus Diseases Branch^L|AHK7@cdc.gov^Lambert^Amy|||20230106162218+0000||||CDC Division of Vector-Borne Infectious Diseases^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^06D0880233|3156 Rampart Road^^Fort Collins^CO^80521^USA^B
SPM|1|IDR2200064353&SPHL-000026&2.16.840.1.114222.4.1.3673&ISO^3029198209&STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO||119364003^Serum specimen^SCT^SER^Serum specimen^L^0912017^Adobe_Code^Serum specimen||||||||||Original material,|||20221227|20230104140813+0000||||||44639001^Dry Ice^SCT^^^^09012017^^Frozen (Dry Ice)
OBR|9|IDR2200064353^SPHL-000026^2.16.840.1.114222.4.1.3673^ISO|72_3029198209_3029198209_783^STARLIMS.CDC.Prod^2.16.840.1.114222.4.3.3.2.1.1^ISO|PLT812^WN+SLE IgM XXX IA-Imp^PLT^783^WN/SLE MIA^L^2.69^v unknown^^CDC-10282^Arbovirus Serology^L^^2.16.840.1.113883.6.1|||20221227|||||||||FTC-3218^Westchester Medical Center^^^^^^^STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO^^^^XX||||||20230601134600-0400|||C
NTE|1|L|Test has not been cleared or approved by the FDA. The Performance characteristics have been establis|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
NTE|2|L|Evidence of recent infection with Powassan virus and a previous infection with a California serogroup virus (likely Jamestown Canyon virus). Clinical correlation required.|RE^Remark^HL70364^^^^2.5.1^^^^^^^2.16.840.1.113883.12.364
OBX|1|CWE|PLT812^WN+SLE IgM XXX IA-Imp^PLT^2720^West Nile/St. Louis Encephalitis IgM MIA^L^2.69^v_unknown^WN/SLE MIA Result|ZZYSDZF4-1|260385009^Negative^SCT^^^^09012018^^Negative||||||C|||20221227|06D0880233^CDC Division of Vector-Borne Infectious Diseases^CLIA^72^Arbovirus Diseases Branch^L|AHK7@cdc.gov^Lambert^Amy|||20230106162838+0000||||CDC Division of Vector-Borne Infectious Diseases^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^06D0880233|3156 Rampart Road^^Fort Collins^CO^80521^USA^B
SPM|1|IDR2200064353&SPHL-000026&2.16.840.1.114222.4.1.3673&ISO^3029198209&STARLIMS.CDC.Prod&2.16.840.1.114222.4.3.3.2.1.1&ISO||119364003^Serum specimen^SCT^SER^Serum specimen^L^0912017^Adobe_Code^Serum specimen||||||||||Original material,|||20221227|20230104140813+0000||||||44639001^Dry Ice^SCT^^^^09012017^^Frozen (Dry Ice)